Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis. Devjani S, Engel PV, Javadi SS, Smith B, et al. Lancet 2023;402:1833-1834.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Devjani S, Engel PV, Javadi SS, Smith B, et al. Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis. Lancet 2023;402:1833-1834.
PMID: 37980089